Evolus, Inc. (EOLS) has a negative trailing P/E of -5.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 21.8 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -19.85%, forward earnings yield 4.58%. PEG 0.22 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
Overall SharesGrow Score: 57/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -10.7 | 0.30 | -30.09 | 0.00 | - |
| 2017 | -60.6 | 0.73 | -3.59 | 0.00 | - |
| 2018 | -6.2 | -0.01 | -2.36 | 0.00 | - |
| 2019 | -3.8 | -0.06 | 4.33 | 9.84 | - |
| 2020 | -0.7 | -0.01 | -1.55 | 2.00 | - |
| 2021 | -6.9 | 0.09 | 3.96 | 3.25 | - |
| 2022 | -5.7 | -0.14 | 22.76 | 2.83 | - |
| 2023 | -9.7 | 0.52 | -28.97 | 2.97 | - |
| 2024 | -13.6 | 0.54 | 123.99 | 2.57 | - |
| 2025 | -8.3 | 6.72 | -18.55 | 1.44 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-1.08 | $0.00 | $-20.07M | - |
| 2017 | $-0.19 | $0.00 | $-4.48M | - |
| 2018 | $-1.92 | $0.00 | $-46.87M | - |
| 2019 | $-3.19 | $34.93M | $-90.03M | -257.8% |
| 2020 | $-4.83 | $56.54M | $-163.01M | -288.3% |
| 2021 | $-0.94 | $99.67M | $-46.81M | -47% |
| 2022 | $-1.33 | $148.62M | $-74.41M | -50.1% |
| 2023 | $-1.08 | $202.09M | $-61.69M | -30.5% |
| 2024 | $-0.81 | $266.27M | $-50.42M | -18.9% |
| 2025 | $-0.80 | $297.18M | $-51.64M | -17.4% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.15 | $-0.52 – $0.30 | $330.02M | $328.24M – $330.98M | 5 |
| 2027 | $0.21 | $0.15 – $0.29 | $388.17M | $381.67M – $395.59M | 4 |
| 2028 | $0.66 | $-0.35 – $1.54 | $459.21M | $459.21M – $459.21M | 6 |
| 2029 | $1.27 | $1.24 – $1.30 | $529.27M | $519.95M – $537.56M | 4 |
| 2030 | $1.66 | $1.62 – $1.69 | $593.29M | $582.84M – $602.58M | 2 |
